[Treatment of sudden perception deafness with clarificants and anticoagulants].
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D001299:Audiometry; D001309:Auditory Threshold; D002784:Cholesterol / Q000097:blood; D003638:Deafness / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D013261:Sterols / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D000925:Anticoagulants; D009539:Nicotinic Acids; D013261:Sterols; D014280:Triglycerides; D014665:Vasodilator Agents; D006493:Heparin; D002784:Cholesterol
Traitement des surdités brusques de perception par les clarifiants et les anticoagulants.